121 related articles for article (PubMed ID: 9033659)
1. 13-cis retinoic acid and interferon-alpha +/- irradiation in the treatment of squamous-cell carcinomas.
Hoffmann W; Schiebe M; Hirnle P; Souchon R; Clemens M; Adamietz I; Bamberg M
Int J Cancer; 1997 Feb; 70(4):475-7. PubMed ID: 9033659
[No Abstract] [Full Text] [Related]
2. [Feasibility study: concurrent 13-cis-retinoic acid, alfa-2a interferon and radiotherapy in the treatment of 23 patients with advanced cervix uteri epidermoid carcinoma].
Paredes Espinoza M; Delgadillo Madrueño F; Paredes Casillas P; Delgadillo Hernández JJ; Ayala Castellanos MM; Alvarez Márquez V; Buenrostro Ahued MA; Arias Castro G
Ginecol Obstet Mex; 1995 May; 63():205-9. PubMed ID: 7789851
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G
Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916
[No Abstract] [Full Text] [Related]
4. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity.
Bläse M; Zaruba MM; Santo-Hoeltje L; Bamberg M; Hoffmann W; Rodemann HP
Strahlenther Onkol; 1999 Nov; 175(11):563-8. PubMed ID: 10584127
[TBL] [Abstract][Full Text] [Related]
5. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group.
Toma S; Bonelli L; Sartoris A; Mira E; Antonelli A; Beatrice F; Giordano C; Benazzo M; Caroggio A; Cavalot AL; Gandolfo S; Garozzo A; Margarino G; Schenone G; Spadini N; Sirotovà Z; Zibordi F; Balzarini F; Serafini I; Miani P; Cortesina G
Oncol Rep; 2004 Jun; 11(6):1297-305. PubMed ID: 15138569
[TBL] [Abstract][Full Text] [Related]
6. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma.
Gravis G; Pech-Gourgh F; Viens P; Alzieu C; Camerlo J; Oziel-Taieb S; Jausseran M; Maraninchi D
Anticancer Drugs; 1999 Apr; 10(4):369-74. PubMed ID: 10378671
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer.
Rinaldi DA; Lippman SM; Burris HA; Chou C; Von Hoff DD; Hong WK
Anticancer Drugs; 1993 Feb; 4(1):33-6. PubMed ID: 8457712
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
[TBL] [Abstract][Full Text] [Related]
10. 13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse.
Lippman SM; Hong WK
Ann Oncol; 1994 May; 5(5):391-3. PubMed ID: 8075044
[No Abstract] [Full Text] [Related]
11. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
[TBL] [Abstract][Full Text] [Related]
12. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
13. Synchronous chemoradiation for squamous carcinomas.
Tobias JS; Ball D
BMJ; 2001 Apr; 322(7291):876-8. PubMed ID: 11302885
[No Abstract] [Full Text] [Related]
14. Squamous cell carcinoma of neck metastasized to the lung and cervical lymph nodes, successfully treated with systemic docetaxel and local radiation therapy to the neck in a renal transplant patient.
Arita T; Asai J; Taura M; Wada M; Takenaka H; Miyashita A; Katoh N
J Dermatol; 2017 Dec; 44(12):e346-e347. PubMed ID: 28862322
[No Abstract] [Full Text] [Related]
15. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856
[TBL] [Abstract][Full Text] [Related]
16. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
Nikolaou AC; Fountzilas G; Daniilidis I
J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297
[TBL] [Abstract][Full Text] [Related]
17. High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomas.
Roth AD; Morant R; Alberto P
Acta Oncol; 1999; 38(5):613-7. PubMed ID: 10427950
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?
Schornagel JH; Verheij M; Bartelink H
Curr Oncol Rep; 2001 Jan; 3(1):1-2. PubMed ID: 11123863
[No Abstract] [Full Text] [Related]
19. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
[TBL] [Abstract][Full Text] [Related]
20. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.
Koukourakis MI; Koukouraki S; Giatromanolaki A; Archimandritis SC; Skarlatos J; Beroukas K; Bizakis JG; Retalis G; Karkavitsas N; Helidonis ES
J Clin Oncol; 1999 Nov; 17(11):3512-21. PubMed ID: 10550149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
